Company / Revenue per Share
BioXcel Therapeutics, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.21
FY2025
5-year range
$0.01 / $0.74
FY2022-FY2025
Trend
-71.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.01 to $0.21 over the past 2 years.
Based on SEC 10-K filings.
0.21 in FY2025 with a 3-year CAGR of +149.0%.
Improved from $0.01 to $0.21 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +149.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 71.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -71.9% |
| FY2024 | $0.74 | +5436.1% |
| FY2023 | $0.01 | -0.6% |
| FY2022 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026